论文信息 - Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial - 字舞流文

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

K. Becker | P. Willeit | L. Forer | S. Schönherr | F. Krammer | D. von Laer | Z. Bánki | B. Müllauer | B. Falkensammer | L. Tschiderer | W. Borena | C. Ower | M. Sacher | J. Kimpel | A. Rössler | L. Seekircher | D. Bante | T. Harthaller | Helena Schäfer | H. Ulmer | Albert Falch | Bianca Neurauter | Maria Huber | Sabine Embacher-Aichhorn | Eva Hochmuth | Luiza Hoch | Lisa-Maria Raschbichler | Evelyn Peer | Zoltán Janine Annika Helena Barbara David Florian Dorothe Bánki Kimpel Rössler Schäfer Falkensammer